Valerie DeBenedette
Valerie DeBenedette is Managing Editor of Drug Topics.
Customers Sue CVS and Walgreens, Claiming PBM Collusion
Class action lawsuits claim that chains colluded with PBMs to overbill customers.
The FDA Warns Against E-Cigarettes
The FDA Warns Against E-Cigarettes
A youth education campaign about e-cigarettes is part of FDA’s tobacco/nicotine plan.
Biosimilar of Remicade Launched
Biosimilar of Remicade Launched
Renflexis has wholesale cost 35% below Remicade.
FDA Approves First Drug for Sickle Cell in 20 Years
Endari is only the second FDA-approved sickle cell disease drug.
Self-Assessment Tool Can Help Improve Medication Safety
Revised ISMP tool helps pharmacies see where they may be missing best practices.
Small Doses: Sex, Drugs, and Other Pharmacy News
Small Doses: Sex, Drugs, and Other Pharmacy News
Easy-to-swallow bits of news from around the world of pharmacy.
Specialty Drugs: Unintended Consequences May Slow the Market
Specialty Drugs: Unintended Consequences May Slow the Market
Report looks at possible impediments to growth in the specialty market, including patient access.
Quiz: How Much Do You Know About Vaccination?
Quiz: How Much Do You Know About Vaccination?
Is your immunization knowledge up-to-date?
Phillips Recalling All Topical Products
The FDA found uncontrolled manufacturing practices.
A First: Cancer Drug Is Approved on Genetic Basis, Not Tumor Location
A First: Cancer Drug Is Approved on Genetic Basis, Not Tumor Location
Pembrolizumab gets FDA approval for cancers with a certain biomarker.

Poll